Having already established a commercial infrastructure for its oral hereditary angioedema (HAE) drug Orladeyo and eager to ...
Any banana you eat today is probably a clone. You may have noticed it doesn’t have seeds. And that’s because nearly every ...
Zacks Investment Research on MSN
NVO, OMER Ink $2.1B Zaltenibart Deal to Bolster Rare Disease Portfolio
Novo Nordisk NVO and Omeros Corporation OMER have announced the signing of a definitive asset purchase and license agreement ...
Neurocrine Biosciences shows strong growth with rising INGREZZA sales, expanding pipeline, and solid financials despite key ...
The Series A funding round was led by General Catalyst, a venture capital firm that has supported the growth of companies ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inheent biology of the adaptive immune system to transform the diagnosis and treatment of ...
Scientists do not fully understand what causes the chronic neurodegenerative disease Alzheimer's, but they are examining a ...
Though some researchers believe it should be labeled endemic in the United States, most Americans don’t need to worry about getting sick. By Simar Bajaj Perhaps you’ve seen the “kissing bug” disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results